Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.
about
Vedolizumab: an α4β7 integrin antagonist for ulcerative colitis and Crohn's diseaseNeuronal COX-2 expression in human myenteric plexus in active inflammatory bowel diseaseSulfasalazine inhibits the synthesis of chemotactic lipids by neutrophilsInflammatory Potential of Diet and Risk of Ulcerative Colitis in a Case-Control Study from IranAddition of Berberine to 5-Aminosalicylic Acid for Treatment of Dextran Sulfate Sodium-Induced Chronic Colitis in C57BL/6 MicePGE2 is a direct and robust mediator of anion/fluid secretion by human intestinal epithelial cells.Monocytes in inflammatory bowel disease: absolute monocyte counts.Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2.A pro-resolution mediator, prostaglandin D(2), is specifically up-regulated in individuals in long-term remission from ulcerative colitis.Antagonizing arachidonic acid-derived eicosanoids reduces inflammatory Th17 and Th1 cell-mediated inflammation and colitis severity.Prostaglandins, thromboxanes and leukotrienes in clinical medicineCrucial role of macrophage selenoproteins in experimental colitis.Inter-relationships between inflammatory mediators released from colonic mucosa in ulcerative colitis and their effects on colonic secretionRole of interleukin 1 in inflammatory bowel disease--enhanced production during active disease.Role of reactive oxygen metabolites in experimental colitis.5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel diseaseIncorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease.Inhibition of red cell membrane lipid peroxidation by sulphasalazine and 5-aminosalicylic acid.Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patientsUse of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel diseaseEnhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis.Papaverine stimulation of prostaglandin E2 production by cultured rabbit gastric mucosaAnalgesic ingestion and other factors preceding relapse in ulcerative colitis.Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease.Inhibition of leucocyte motility by drugs used in ulcerative colitisImbalance of prostacyclin and thromboxane synthesis in Crohn's disease.Mechanism of chloride secretion induced by carbachol in a colonic epithelial cell lineEffects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitisEffect of glucocorticoids on rectal transport in normal subjects and patients with ulcerative colitisOlsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind studyChloride secretory mechanism induced by prostaglandin E1 in a colonic epithelial cell line.Anti-inflammatory effects of freeze-dried black raspberry powder in ulcerative colitisThe prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gutFive-aminosalicylic Acid: an update for the reappraisal of an old drugBradykinin-stimulated electrolyte secretion in rabbit and guinea pig intestine. Involvement of arachidonic acid metabolitesThe role of PGE2 in intestinal inflammation and tumorigenesis.Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper
P2860
Q26786018-DE189683-B445-4622-8981-14904EE5D461Q28360085-B99E637B-D17F-4AF1-8A2B-301A4DEBB82BQ28365743-E95407EF-9465-46BB-9068-9C5C7591CF26Q28395360-051A64F0-ADDD-4F88-8AFA-FC6C5E125D85Q28551369-36755A81-D5E5-4D6C-82A8-1A46923B95C3Q28821807-27C04F6A-865E-4F1F-8F17-590A33A634BDQ33848357-49B9F651-A24C-431A-80FB-35EEB970C26DQ33938703-8E6ED5F1-426A-4D2D-A6D9-AAF1CEC31E27Q33977744-F659FC19-0D9D-4237-B377-48A2B69B4FFBQ34022356-A3F51776-C023-4E49-8F0C-2031A748DA9FQ34192889-E4B93CCB-CD01-48CF-A60A-01DEAEED9576Q34218777-62E9BCEB-481F-444E-90C1-296D04F030DCQ34377239-52A3F32D-1993-4C46-824C-AB0ED112756AQ34392301-7B085699-4CFA-4DC2-AF38-2B50BF5394FDQ34392446-5E45C7CF-989A-4150-9BC0-855680468BA5Q34394984-338F63BE-88F7-4AFF-BAAB-01987F3D9923Q34395609-973A4830-8FED-45E8-BF1F-3F7F7E4EB574Q34395621-DD4E3C60-D30A-497B-B2A1-9D28A0B1FA0FQ34396133-28D7D8FA-6C84-4D33-815F-1446C0FFC333Q34396413-B8717506-3B1F-429D-83D3-68167EE9B0D3Q34408295-125A4E20-A29B-4A8C-87BB-17E8E17A8564Q34408472-B4D78450-E74E-4AEE-B598-4FEBCBF9E13FQ34409842-9CCD040C-CC59-4BDF-8CC3-F505A6084566Q34476230-94ABDF55-9589-4CA0-9B1A-C0E35EACEA8DQ34495790-119E4FAC-70A1-4598-9B2C-6DCA32880492Q34496019-C3473331-F401-4F7A-B13E-AB888E1C213DQ34496132-2C467B8C-4E75-4DD3-987C-56713201760AQ34496305-23C12BED-9883-4B7B-BEA2-35796514E2AAQ34520348-06C994EF-405B-4BC7-8A79-44335A9547FAQ34525348-7D828031-0802-45D2-8427-853356B929EDQ34528312-22244647-2696-463A-802C-8281C97609C8Q34529329-B64BCE49-89DF-4C91-A4F9-D12FD6629B55Q34532266-C591834C-6C16-4181-BA16-0A3F54BE86E9Q34564507-C8C37EC4-218C-4428-961E-E29CBBB33831Q34617208-05D5794E-B1D3-4A6E-BA55-B38C6451AF48Q34790350-D559598E-B87A-4D78-BE2F-71498C9768ADQ35061210-D855D3AF-94D8-407D-8DE5-950794C054D1Q35206157-7C3E1626-BE96-4078-B7DC-E04D29129154Q35269711-31890B45-C30E-4734-A4A9-F12BA5AFEF66Q35359745-C16409CE-60AA-4FDF-9F9A-35AF5AA7B441
P2860
Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
Role of prostaglandins in ulce ...... d inhibition by sulfasalazine.
@en
Role of prostaglandins in ulce ...... d inhibition by sulfasalazine.
@nl
type
label
Role of prostaglandins in ulce ...... d inhibition by sulfasalazine.
@en
Role of prostaglandins in ulce ...... d inhibition by sulfasalazine.
@nl
prefLabel
Role of prostaglandins in ulce ...... d inhibition by sulfasalazine.
@en
Role of prostaglandins in ulce ...... d inhibition by sulfasalazine.
@nl
P2093
P1433
P1476
Role of prostaglandins in ulce ...... d inhibition by sulfasalazine.
@en
P2093
P304
P407
P577
1978-10-01T00:00:00Z